Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

43
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
43
Pyloric Obstruction01:11

Pyloric Obstruction

34
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
34
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

42
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
42
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

1.5K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.5K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

999
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
999

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Friend and Confidant Thresholds: Social Network Size as a Mediator Between Marital Status and Major Depressive Disorder.

Depression and anxiety·2026
Same author

Clinical Outcomes and Prognostic Factors in Older Adult Patients Aged ≥75 Years With Early Gastric Cancer After Endoscopic Resections: A Nationwide Cohort Study.

Journal of gastric cancer·2026
Same author

Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study.

NPJ precision oncology·2026
Same author

Optimal Sampling Site for the Diagnosis of <i>Helicobacter pylori</i> Infection with the Rapid Urease Test: A Prospective Cohort Study.

Gut and liver·2026
Same author

Endoscopic submucosal dissection for synchronous early hypopharyngeal and esophageal squamous cell carcinoma: a case report with 24-month follow-up.

International journal of surgery case reports·2026
Same author

New Measurement Method for Lateral Acromial Protrusion as an Alternative to Critical Shoulder Angle, Independent of Sagittal Glenoid Tilt.

Clinics in orthopedic surgery·2026

Related Experiment Video

Updated: Apr 28, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.8K

Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features.

Ji Yong Ahn1, Da Hye Son2, Kee Don Choi1

  • 1Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Asan Digestive Disease Research Institute, Seoul, Korea.

Gastrointestinal Endoscopy
|June 16, 2014
PubMed
Summary

Larger gastric hyperplastic polyps (>1 cm) may signal neoplasms. Loss of p16 and high Ki-67 expression are potential markers for hyperplastic polyp-associated dysplasia.

More Related Videos

Diagnosis of Neoplasia in Barrett&#8217;s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

10.5K
Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach
08:45

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach

Published on: January 26, 2024

2.1K

Related Experiment Videos

Last Updated: Apr 28, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.8K
Diagnosis of Neoplasia in Barrett&#8217;s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

10.5K
Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach
08:45

Author Spotlight: Generation of and Comparison Between Patient-Derived Gastric Organoids from Different Regions of the Stomach

Published on: January 26, 2024

2.1K

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Gastric hyperplastic polyps (HPs) are common, but the risk of neoplasms arising from them is not well understood.
  • Investigating risk factors and molecular pathways in HP-associated neoplasms is crucial for early detection and management.

Purpose of the Study:

  • To identify risk factors for neoplasms within gastric hyperplastic polyps.
  • To evaluate the role of the p16-cyclin D1-pRb pathway in the malignant transformation of HPs.

Main Methods:

  • Retrospective case-control study involving 809 HPs >1 cm.
  • Comparison of 30 HPs with neoplasms (case group) against 30 HPs without neoplasms (control group).
  • Immunohistochemical analysis of p16, cyclin D1, p53, and Ki-67 expression.

Main Results:

  • Neoplasms in HPs were associated with older patient age, larger polyp size, and polyp lobulation.
  • Loss of p16 expression and high Ki-67 expression were significantly observed in dysplastic areas of HPs with neoplasms.
  • No significant differences in molecular markers were found in non-dysplastic areas between groups.

Conclusions:

  • Gastric hyperplastic polyps larger than 1 cm warrant further investigation for associated neoplasms.
  • Loss of p16 and high Ki-67 expression may serve as biomarkers for hyperplastic polyp-associated dysplasia.
  • These findings contribute to understanding HP malignant transformation and risk stratification.